Indirect ELISA using recombinant nonstructural protein 3D to detect foot and mouth disease virus infection associated

Sonalika Mahajan1, Jajati Keshari Mohapatra1, Laxmi Kant Pandey1

  • 1Indian Council of Agricultural Research, IVRI Campus, Mukteswar, Uttarakhand 263138, India.

Insights

A new indirect ELISA (I-ELISA) using the 3D protein of Foot-and-mouth disease virus (FMDV) shows high sensitivity for detecting infected bovines. However, its lower specificity in vaccinated animals limits its use in routine surveillance programs.

Area of Science:

  • Veterinary Virology
  • Immunodiagnostics
  • Disease Surveillance

Background:

  • Foot-and-mouth disease (FMD) is a highly contagious transboundary animal disease.
  • Control strategies in India rely on vaccination and surveillance.
  • Differentiating infected from vaccinated animals (DIVA) is crucial for effective FMD management.

Purpose of the Study:

  • To develop and evaluate an indirect ELISA (I-ELISA) for detecting antibodies against the FMD virus 3D protein.
  • To assess the diagnostic performance of the 3D I-ELISA in differentiating infected from vaccinated bovines.

Main Methods:

  • The FMD virus 3D protein was expressed in Escherichia coli.
  • An indirect ELISA (I-ELISA) was developed using the recombinant 3D protein.
  • Diagnostic sensitivity and specificity were determined by comparing results with an in-house r3AB3 I-ELISA and known infected/vaccinated samples.

Main Results:

  • The 3D I-ELISA demonstrated high diagnostic sensitivity (97.6%).
  • Overall specificity was 80.8%, with significant variations: 98.42% for naïve and 76.93% for vaccinated samples.
  • A moderate concordance (88.5%) was observed between the 3D I-ELISA and the r3AB3 I-ELISA.

Conclusions:

  • The 3D I-ELISA shows promise for seroepidemiological investigations in non-vaccinated regions due to its high sensitivity and persistent antibody detection.
  • Its lower specificity in vaccinated populations makes it unsuitable for routine serosurveillance in intensively vaccinated areas.
  • The assay could be extended to non-bovine susceptible species not covered by vaccination programs.